
    
      OBJECTIVES:

        -  To use a simple 2-page survey to gather preliminary information on why patients or
           parents/guardians (if patient is a minor) do or do not agree to participate in the
           optional pharmacokinetic portion of a phase I treatment study while consenting to
           participate in the phase I treatment study.

      OUTLINE: This is a multicenter study.

      Patients or parents/guardians (if patient is a minor) complete a short questionnaire on the
      reasons for agreeing/declining to participation in the optional pharmacokinetic sampling
      component of the phase I clinical trial.

      Patient demographics and other relevant information are collected.
    
  